July 27, 2015
Anthem Blue Cross is wrongfully withholding Gilead Sciences Inc.'s newly approved yet expensive treatment for hepatitis C by claiming policyholders aren't sick enough to get it, a practice that violates ERISA law, according to a putative class action filed Friday in California federal court.